Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Elsberger

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Cancer Drug Targets|June 29, 2010
Is Src a viable target for treating solid tumours?B Elsberger, B Stewart, O Tatarov, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 6, 2007
Self-expanding metallic stent insertion in the proximal colonB Elsberger, K Rourke, J Brush, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2011
Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatmentB Elsberger, D M Paravasthu, S M Tovey, et al.
British Journal of Cancer|November 11, 2010
Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survivalB Elsberger, B A Tan, E A Mallon, et al.
Prostate Cancer and Prostatic Diseases|March 2, 2011
Presence of tumoural C-reactive protein correlates with progressive prostate cancerB Elsberger, L Lankston, D C McMillan, et al.
British Journal of Cancer|August 29, 2013
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancerZ M A Mohammed, J J Going, J Edwards, et al.
British Journal of Cancer|August 11, 2012
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancerZ M A Mohammed, J J Going, J Edwards, et al.
British Journal of Cancer|February 19, 2009
Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997S B F Brown, E A Mallon, J Edwards, et al.
British Journal of Cancer|March 31, 2012
Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancerJ Ohotski, J S Long, C Orange, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2013
Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapyB Elsberger, A Romsauerova, S Vinnicombe, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Cancer Drug Targets|June 29, 2010
Is Src a viable target for treating solid tumours?B Elsberger, B Stewart, O Tatarov, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 6, 2007
Self-expanding metallic stent insertion in the proximal colonB Elsberger, K Rourke, J Brush, et al.
Journal of Cancer Research and Clinical Oncology|December 3, 2011
Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatmentB Elsberger, D M Paravasthu, S M Tovey, et al.
British Journal of Cancer|November 11, 2010
Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survivalB Elsberger, B A Tan, E A Mallon, et al.
Prostate Cancer and Prostatic Diseases|March 2, 2011
Presence of tumoural C-reactive protein correlates with progressive prostate cancerB Elsberger, L Lankston, D C McMillan, et al.
British Journal of Cancer|August 29, 2013
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancerZ M A Mohammed, J J Going, J Edwards, et al.
British Journal of Cancer|August 11, 2012
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancerZ M A Mohammed, J J Going, J Edwards, et al.
British Journal of Cancer|February 19, 2009
Is the biology of breast cancer changing? A study of hormone receptor status 1984-1986 and 1996-1997S B F Brown, E A Mallon, J Edwards, et al.
British Journal of Cancer|March 31, 2012
Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancerJ Ohotski, J S Long, C Orange, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 17, 2013
Comparison of mammographic findings after intraoperative radiotherapy or external beam whole breast radiotherapyB Elsberger, A Romsauerova, S Vinnicombe, et al.
Pageof 2